tiprankstipranks
Acusphere Inc (ACUS)
OTHER OTC:ACUS
US Market

Acusphere (ACUS) Price & Analysis

5 Followers

ACUS Stock Chart & Stats

$0.25
$0.00(0.00%)
At close: 4:00 PM EST
$0.25
$0.00(0.00%)

ACUS FAQ

What was Acusphere Inc’s price range in the past 12 months?
Acusphere Inc lowest stock price was $0.25 and its highest was $0.25 in the past 12 months.
    What is Acusphere Inc’s market cap?
    Acusphere Inc’s market cap is $5.00.
      When is Acusphere Inc’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Acusphere Inc’s earnings last quarter?
      Currently, no data Available
      Is Acusphere Inc overvalued?
      According to Wall Street analysts Acusphere Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Acusphere Inc pay dividends?
        Acusphere Inc does not currently pay dividends.
        What is Acusphere Inc’s EPS estimate?
        Acusphere Inc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Acusphere Inc have?
        Acusphere Inc has 4,951,000 shares outstanding.
          What happened to Acusphere Inc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Acusphere Inc?
          Currently, no hedge funds are holding shares in ACUS
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            Acusphere Inc

            Acusphere, Inc. is a pharmaceutical firm specializing in the creation and market launch of cardiovascular treatments. Its flagship product is Imagify (perflubutane polymer microspheres), a cardiovascular medication designed to assess myocardial perfusion and aid in the diagnosis of coronary artery disease. This drug is administered as an injectable suspension. Initially established as Polymers For Medicine, Inc., the organization rebranded as Acusphere, Inc. in March 2004. Founded in 1993, the company maintains its headquarters in Watertown, Massachusetts.
            Similar Stocks
            Company
            Price & Change
            Follow
            RedHill Biopharma
            Aytu BioScience
            Cumberland Pharmaceuticals
            PainReform
            Popular Stocks